Complement factors D and C3 cross-sectionally associate with arterial stiffness, but not independently of metabolic risk factors

D

[1]  R. Kurosawa,et al.  Identification of Adipsin as a Novel Prognostic Biomarker in Patients With Coronary Artery Disease , 2019, Journal of the American Heart Association.

[2]  D. Levy,et al.  Adipsin preserves beta cells in diabetic mice and associates with protection from type 2 diabetes in humans , 2019, Nature Medicine.

[3]  Chack-Yung Yu,et al.  Relationships of Complement Components C3 and C4 and their Genetics to Cardiometabolic Risk in Healthy, Non-Hispanic White Adolescents , 2019, Pediatric Research.

[4]  M. Woodward.  Rationale and tutorial for analysing and reporting sex differences in cardiovascular associations , 2019, Heart.

[5]  D. Schlessinger,et al.  Arterial stiffness and multiple organ damage: a longitudinal study in population , 2019, Aging Clinical and Experimental Research.

[6]  E. Feskens,et al.  The Maastricht FFQ: Development and validation of a comprehensive food frequency questionnaire for the Maastricht study. , 2019, Nutrition.

[7]  P. Gao,et al.  Role of Complement-Related Inflammation and Vascular Dysfunction in Hypertension , 2019, Hypertension.

[8]  A. Blom,et al.  Complement Component C3 Is Highly Expressed in Human Pancreatic Islets and Prevents β Cell Death via ATG16L1 Interaction and Autophagy Regulation. , 2019, Cell metabolism.

[9]  L. Trouw,et al.  Age and Sex-Associated Changes of Complement Activity and Complement Levels in a Healthy Caucasian Population , 2018, Front. Immunol..

[10]  C. Stehouwer,et al.  Longitudinal associations of the alternative and terminal pathways of complement activation with adiposity: The CODAM study. , 2017, Obesity research & clinical practice.

[11]  Sanjiv J. Shah,et al.  Brief Report: Association of Elevated Adipsin Levels With Pulmonary Arterial Hypertension in Systemic Sclerosis , 2017, Arthritis & rheumatology.

[12]  P. Nilsson,et al.  Acute phase proteins as prospective risk markers for arterial stiffness: The Malmö Diet and Cancer cohort , 2017, PloS one.

[13]  E. Feskens,et al.  Development and evaluation of the Dutch Healthy Diet index 2015 , 2017, Public Health Nutrition.

[14]  Dean Y. Li,et al.  Small Molecule-Induced Complement Factor D (Adipsin) Promotes Lipid Accumulation and Adipocyte Differentiation , 2016, PloS one.

[15]  E. Feskens,et al.  The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes , 2016, Thrombosis and Haemostasis.

[16]  C. Stehouwer,et al.  The complement system in human cardiometabolic disease. , 2014, Molecular immunology.

[17]  Diti Chatterjee Bhowmick,et al.  Adipsin Is an Adipokine that Improves β Cell Function in Diabetes , 2014, Cell.

[18]  E. Feskens,et al.  Complement Factor 3 Is Associated With Insulin Resistance and With Incident Type 2 Diabetes Over a 7-Year Follow-up Period: The CODAM Study , 2014, Diabetes Care.

[19]  P. Dagnelie,et al.  The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities , 2014, European Journal of Epidemiology.

[20]  J. Manson,et al.  Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases , 2013, Genome Medicine.

[21]  D. Nurminsky,et al.  Two Sides of MGP Null Arterial Disease , 2013, The Journal of Biological Chemistry.

[22]  D. Arveiler,et al.  Adipocytokines and the risk of ischemic stroke: The PRIME Study , 2012, Annals of neurology.

[23]  Cosmin A. Tegla,et al.  Membrane attack by complement: the assembly and biology of terminal complement complexes , 2011, Immunologic research.

[24]  Simon C Watkins,et al.  Complement Proteins C3 and C4 Bind to Collagen and Elastin in the Vascular Wall: A Potential Role in Vascular Stiffness and Atherosclerosis , 2011, Clinical and translational science.

[25]  P. Gao,et al.  Perivascular Adipose Tissue-Derived Complement 3 Is Required for Adventitial Fibroblast Functions and Adventitial Remodeling in Deoxycorticosterone Acetate-Salt Hypertensive Rats , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Michael J. Pencina,et al.  Arterial Stiffness and Cardiovascular Events: The Framingham Heart Study , 2010, Circulation.

[27]  J. Köhl,et al.  The role of the anaphylatoxins in health and disease. , 2009, Molecular immunology.

[28]  D. Vorp,et al.  Relative Contributions of Age and Atherosclerosis to Vascular Stiffness , 2008, Clinical and translational science.

[29]  R. Shohet,et al.  In vivo endothelial gene regulation in diabetes , 2008 .

[30]  C. D. A. Stehouwer,et al.  Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease , 2008, Diabetologia.

[31]  G. Berglund,et al.  Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study , 2007, Journal of Human Hypertension.

[32]  J. Staessen,et al.  Obesity is associated with increased arterial stiffness from adolescence until old age , 2005, Journal of hypertension.

[33]  D. Kass,et al.  Mechanisms, pathophysiology, and therapy of arterial stiffness. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[34]  P. Moreau,et al.  Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension. , 2005, Cardiovascular research.

[35]  K. Eriksson,et al.  Complement C3 is a risk factor for the development of diabetes: a population-based cohort study. , 2005, Diabetes.

[36]  T. McGuire,et al.  Pentoxifylline inhibits tumor necrosis factor-alpha induced synthesis of complement component C3 in human endothelial cells. , 2004, Biological & pharmaceutical bulletin.

[37]  Noboru Fukuda,et al.  Complement 3 Is Involved in the Synthetic Phenotype and Exaggerated Growth of Vascular Smooth Muscle Cells From Spontaneously Hypertensive Rats , 2004, Hypertension.

[38]  Ahmad Qasem,et al.  Endothelin-1 regulates arterial pulse wave velocity in vivo. , 2003, Journal of the American College of Cardiology.

[39]  Mark A. Creager,et al.  Endothelium-Derived Nitric Oxide Regulates Arterial Elasticity in Human Arteries In Vivo , 2001, Hypertension.

[40]  P. Puddu,et al.  Association of serum C3 levels with the risk of myocardial infarction. , 1995, The American journal of medicine.

[41]  B. Spiegelman,et al.  Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. , 1992, The Journal of biological chemistry.

[42]  Na Hyun Kim,et al.  Cross-sectional and longitudinal association between hemoglobin concentration and hypertension , 2016, Medicine.

[43]  E. Feskens,et al.  Distinct associations of complement C3a and its precursor C3 with atherosclerosis and cardiovascular disease , 2014, Thrombosis and Haemostasis.

[44]  D. Arveiler,et al.  Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study , 2010, International Journal of Obesity.

[45]  G. Palomaki,et al.  Reference distributions for complement proteins C3 and C4: A practical, simple and clinically relevant approach in a large cohort , 2004, Journal of clinical laboratory analysis.

[46]  H. Colten,et al.  Complement C3 deficiency: human, animal, and experimental models. , 1994, Pathobiology : journal of immunopathology, molecular and cellular biology.

[47]  Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia Report of a Who/idf Consultation Who Library Cataloguing-in-publication Data , 2022 .